Ishares Biotechnology Etf Analysis

IShares Etf Analysis Notes

IShares Biotechnology is is formed as Regulated Investment Company in the United States. ETF is managed and operated by JPMorgan Chase Bank, N.A.. The fund has 224 constituents with avarage daily trading value of 1.5 M. The fund charges 0.44 percent management fee with a total expences of 0.44 percent of total asset. The fund retains 99.93% of assets under management (AUM) in equities. iShares Biotechnology ETF last dividend was 0.3932 per share. The fund generally will invest at least 80 percent of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents. Nasdaq Biotechnology is traded on NASDAQ Exchange in the United States. To learn more about iShares Biotechnology ETF call the company at NA.

Sector Exposure

iShares Biotechnology ETF Investment Alerts

IShares Biotechnology Thematic Classifications

IShares Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 9.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate IShares Biotechnology's market, we take the total number of its shares issued and multiply it by IShares Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. iShares Biotechnology ETF invests in 214 different instruments across multiple market segments that include assets with varying market capitalizations.

Management Efficiency

IShares Biotechnology's management efficiency ratios could be used to measure how well IShares Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.

Top iShares Biotechnology ETF Etf Constituents

Institutional Etf Holders for IShares Biotechnology

Note, although IShares Biotechnology's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Technical Drivers

As of the 18th of April 2024, IShares Biotechnology retains the Standard Deviation of 1.05, market risk adjusted performance of (0.1), and Risk Adjusted Performance of (0.07). IShares Biotechnology technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices. Simply put, you can use this information to find out if the entity will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have analyzed thirteen technical drivers for iShares Biotechnology ETF, which can be compared to its competitors. Please check out iShares Biotechnology ETF treynor ratio, and the relationship between the variance and value at risk to decide if IShares Biotechnology is priced fairly, providing market reflects its last-minute price of 124.64 per share.

iShares Biotechnology ETF Price Movement Analysis

IShares Biotechnology Predictive Daily Indicators

IShares Biotechnology Forecast Models

IShares Biotechnology's time-series forecasting models are one of many IShares Biotechnology's etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary IShares Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Etf analysis is the technique used by a trader or investor to examine and evaluate how IShares Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling IShares shares will generate the highest return on investment. We also built our etf analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Etf such as IShares Biotechnology. By using and applying IShares Etf analysis, traders can create a robust methodology for identifying IShares entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Biotechnology ETF. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the iShares Biotechnology ETF information on this page should be used as a complementary analysis to other IShares Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

The market value of iShares Biotechnology ETF is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is IShares Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Biotechnology's market value can be influenced by many factors that don't directly affect IShares Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between IShares Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.